13
Views
39
CrossRef citations to date
0
Altmetric
Original Article

Campylobacter-Like Organisms and Gastritis: Histopathology, Bile Reflux, and Gastric Fluid Composition

, , , , &
Pages 478-486 | Received 26 Jun 1986, Accepted 03 Dec 1986, Published online: 08 Jul 2009
 

Abstract

We studied a prospective series of 107 randomly chosen dyspepsia patients without gastric ulcer for the association of spiral Campylobacter-like organisms (CLO) with features of antral and fundal gastritis and duodenogastric reflux. CLO were observed in 38% of the patients. The scores for all classes of inflammatory cells in both antral and body mucosa were significantly higher in the CLO-positive patients than in the CLO-negative ones (p <0.001), and foveolar hyperplasia was also associated with CLO (p < 0.05). Metaplasia and glandular atrophy in the antral mucosa were significantly commoner in the CLO-positive group (p < 0.05 and p < 0.01, respectively). The body gastritis score correlated significantly with age in the CLO-negative patients (R = 0.33, p < 0.01) but not in the CLO-positive ones. There were no significant differences between the groups with regard to duodenogastric reflux or intragastric pH. The results confirm that CLO are associated with gastritis, most notably superficial gastritis in the body and atrophic gastritis in the antrum, but their aetiological significance remains to be proved.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.